How this Houston innovator created a whole new type of business to revolutionize the workplace for new moms

Houston innovators Podcast episode 105

Abbey Donnell created a service before employers even knew they needed it. Photo courtesy of Work & Mother

Abbey Donnell always thought she'd run her own business one day. But did she think she'd start a business that builds out and runs lactation suites as an employee amenity within office buildings? No, she can't say that she did.

However, that's what she's done with Work & Mother, a growing Houston-based business that's both a real estate play and a femtech company. Donnell was working in the advertising and marketing industry and moonlighting as an MBA student at Rice University when the idea came to her. She saw her friends starting having kids and saw how they struggled with the return to work. If they forgot essential supplies for pumping, they'd have to run to the store real quick. Or, they'd have to pump in a room that sacrificed privacy, cleanliness, and/or comfort.

It's something women are hesitant to advocate for themselves, Donnell says on this week's episode of the Houston Innovators Podcast, adding that they are more willing to just deal with the lack of appropriate facilities than raise a fuss. Through her work at Rice and an early pilot in an office building, Donnell essentially started a whole new type of business.

"We created this service for commercial office buildings," Donnell says, explaining that the business works directly with office building landlords to build out the facility. "The new business model creates a win-win-win scenario because it's more cost efficient and is a better solution for all parties, as well as adding privacy and being more streamlined."

In addition to the facilities, which are decorated in a spa-like way that adds comfort to the rooms, Work & Mother adds on to its amenities service with a smartphone app for new moms working in the building to book their pumping room.

The fact that Work & Mother is created a whole new type of service has presented Donnell with a unique set of challenges. For one, fundraising has been a process that includes educating potential investors — most of which are likely men without personal experience with the burden new moms face.

"We're in a strange niche of the industry. We don't really fall completely into a real estate bucket and we don't fall completely into a tech bucket," Donnell says. "It makes finding investors who really understand what we're doing a little bit trickier."

Despite the challenges, Work & Mother has gotten some traction coming out of the pandemic — something that has benefited the business model in that more people are aware of the importance of sanitation and staying healthy in the workplace. Work & Mother has two open locations now with more on the horizon — including expanding outside of Texas thanks to a partnership with CBRE.

Donnell discusses the partnership and the future of Work & Mother on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.

UH's business school has been recognized for innovation and entrepreneurship. Photo via bauerticker.uh.edu

Houston health tech company raises $8M, former WeWork exec has a new gig, UH programs recognized, and more innovation news

Short stories

Hitting headlines this month are innovation news stories from sustainability and education to funding and startup competitions.

In this innovation news roundup, two health-focused startups raise money, the University of Houston earns two pats on the back, a Houston-based former WeWork exec joined the C-suite of a sustainable clothing company, and more.

BrainCheck closes $8 million series A round

BrainCheck has received funding to grow its cognitive assessment platform. Photo via braincheck.com

Houston-based BrainCheck, a cognitive health tech platform closed its $8 million series A funding round. Austin-based S3 Ventures and Chicago-based Tensility Venture Partners co-led the round, and Austin-based True Wealth Ventures and Kansas-based Nueterra Capital also contributed to the round.

BrainCheck's digital platform allows physicians to better assess cognitive function in their patients. The new funds will be used for research and development, including customizing the platform's algorithm for an enhanced patient experience, according to a news release.

"Cognitive healthcare should be an end-to-end solution where problems can be assessed early, and results shared between patients and physicians," says Dr. Yael Katz, co-founder and CEO of BrainCheck, in the release. "By analyzing multiple forms of data, BrainCheck helps physicians create and fine tune personalized interventions. This not only improves outcomes for current patients, but is invaluable to developing management and treatment strategies for future generations."

Former WeWork exec Emily Keeton joins C-suite of a sustainable clothing startup

Goodfair has created a digital thrifting platform. Photo via goodfair.com

After a little over two years at WeWork in leadership positions, Emily Keeton has left the coworking space company to join a Houston startup. Keeton, who was among the founders of Station Houston, is now the chief operating officer at Goodfair, a direct-to-consumer thrift platform based in Houston.

"The rise of fast fashion is contributing to major environmental change," she tells InnovationMap. "Right now, the average American buys 68 new garments a year and wears each one only 7 times. Clothing production is responsible for over 20 percent of all industrial water pollution."

Keeton says she was connected with Goodfair's CEO, Topper Luciani, through the company's lead investor, Paul Bricault of California-based Amplify. Luciani just moved to Houston, and the company also has a warehouse here.

Goodfair sells bundles of "pre-loved" clothes based on size and category at a low price point.

"You know you'll get a medium flannel shirt, but you don't know exactly what color. If you don't like it, you can get a new order for the cost of shipping only," Keeton says. "We have created an entirely new model for this industry, which is an over $14 billion market."

NurseDash raises bridge round as the startup braces for growth

Houston-based NurseDash is the Uber of staffing nursing shifts in medical facilities. Photo via nursedash.com

A growing Houston startup has received bridge funding ahead of opening a larger round. NurseDash, a digital staffing tool for nurses and medical facilities, has received $500,000 from East Coast-based SEI Ventures.

The corporate-backed fund has contributed greatly to higher education institutions, like Capella University, which has a large nursing program.

"Some of the ways we think we can help NurseDash accelerate their growth is getting getting word out to Capella's tens of thousands of alumni and hundreds of employer partners to make sure they are aware of the advantages of the platform, and potentially organizing an educational partnership as well," Taylor Chapman, Houston native and principal at SEI Ventures, tells InnovationMap.

NurseDash, which launched in 2017, now has a presence in 80 facilities on the platform and over 1,000 clinician users in Houston, Austin, and Northeast Ohio.

"We are excited to have SEI join us as a strategic investor and the opportunity that it brings for us to provide enhanced educational opportunities to our clinicians as well as greater exposure the wonderfully talented group that comprises the alumni and nursing students of Cappella University," says CEO and Co-founder Jake Kohl in an email.

University of Houston programs receive recognition

The University of Houston's business school has been recognized for two of its programs. Photo courtesy of University of Houston

The University of Houston's business school has two more feathers to add to its cap.

Bloomberg BusinessWeek named the MBA program at the C. T. Bauer College of Business as among the world's best programs for entrepreneurs. The program tied for ninth in the B- category out of 126 programs surveyed.

"Bauer students indeed reflect the values of our beloved Houston," Professional Programs Associate Dean Leiser Silva says in a news release. "Like our city, they have grit, they are resilient, and they are the bearers of an unparalleled ingenuity. It is in their character to assume calculated risks and be entrepreneurs."

Meanwhile, Bauer's Stimulating Urban Renewal through Entrepreneurship received the 2019 Award of Excellence for Innovation + Talent at the recent University Economic Development Association annual summit. The program creates a partnership between UH students and local entrepreneurs and area business leaders.

"At the heart of the program is experiential learning for our students, along with a commitment to service and civic engagement," says SURE™ founder and director Saleha Khumawala, in a news release.

Capital Factory seeks Texas companies for artificial intelligence challenge

blockchain

Capital Factory is looking for AI companies to compete for $100,000. Getty Images

Austin-based Capital Factory, which has a statewide presence, is looking for startups with artificial intelligence technologies.

The $100,000 Artificial Intelligence Challenge is asking companies to submit their solutions to four key challenges decided by the Army Artificial Intelligence Task Force. The four challenges are: Intelligence support for long-range precision, automated threat recognition for the next-generation combat vehicle, human resources and talent management, and predictive maintenance for military assets.

The competition will conclude on November 12th, at Capital Factory's Defense Innovation Summit. Five technology finalists will be judged by a panel, and one will receive a $100,000 investment that day. The deadline to apply online is October 21.

Work & Mother announces new location

Houston-based Work & Mother is rethinking how new mothers pump in the office. Courtesy of Work & Mother

Houston startup Work & Mother, which runs lactation centers for new moms returning to work, has another location opening. Brookfield Properties announced that Work & Mother has signed a lease for a 949-square-foot space at Three Allen Center at 333 Clay St. in downtown Houston with an expectation top open next summer.

"We are thrilled to partner with Brookfield Properties on this project. We've found that companies aren't equipped to fully address such a private and intimate issue as pumping breast milk in the office," says Abbey Donnell, founder and CEO, in a news release. "It doesn't make sense for every company in a large office tower to take this on individually. Work & Mother is a better economic option for companies in that they reduce their legal risks and create a better working environment, preserving their own office space for their core business."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.

View All Listings